1-2 of 2
Penny Fang
Close
Sort by
Journal Articles

Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma

Clinical Trials & Observations
Raphael E. Steiner, Steven R. Hwang, Arushi Khurana, Thomas M. Habermann, Narendranath Epperla, Kaitlin Annunzio, Pamela Blair Allen, Katelin Baird, Darina Paulino, Juan Pablo Alderuccio, Izidore S. Lossos, Kevin David, Andrew M. Evens, Karan Pandya, Steven M. Bair, Manali Kamdar, Sheeba Ba Aqeel, Pallawi Torka, Ryan Lynch, Stephen Smith, Lei Feng, Mansoor Noorani, Sairah Ahmed, Ranjit Nair, Francisco Vega, Susan Wu, Penny Fang, Chelsea C. Pinnix, Jillian R. Gunther, Bouthaina S. Dabaja, Hun J. Lee
Journal: Blood Advances
Blood Adv (2023) 7 (24): 7485–7493.
https://doi.org/10.1182/bloodadvances.2023010700
Published: 2023
Includes: Supplemental data
Journal Articles

Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma

Clinical Trials & Observations
Chelsea C. Pinnix, Jillian R. Gunther, Bouthaina S. Dabaja, Paolo Strati, Penny Fang, Misha C. Hawkins, Sherry Adkins, Jason Westin, Sairah Ahmed, Luis Fayad, Hun Ju Lee, Ranjit Nair, Raphael E. Steiner, Swaminathan P. Iyer, M. Alma Rodriguez, Michael Wang, Christopher Flowers, Sattva S. Neelapu, Loretta J. Nastoupil
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2871–2883.
https://doi.org/10.1182/bloodadvances.2020001837
Published: 2020